Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 13589-77-0 | MDL No. : | MFCD18071544 |
Formula : | C10H9N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FSMPZHMHKJEXDT-UHFFFAOYSA-N |
M.W : | 187.20 | Pubchem ID : | 83596 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 54.24 |
TPSA : | 60.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.04 cm/s |
Log Po/w (iLOGP) : | 1.51 |
Log Po/w (XLOGP3) : | 0.56 |
Log Po/w (WLOGP) : | 0.82 |
Log Po/w (MLOGP) : | 1.26 |
Log Po/w (SILICOS-IT) : | 0.83 |
Consensus Log Po/w : | 1.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.92 |
Solubility : | 2.24 mg/ml ; 0.012 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.41 |
Solubility : | 7.26 mg/ml ; 0.0388 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.89 |
Solubility : | 0.239 mg/ml ; 0.00128 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.01 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 132274-70-5 ]
1-Phenyl-1H-pyrazole-5-carbaldehyde
Similarity: 0.75
[ 867130-83-4 ]
4-Amino-6-chloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.75
[ 14305-08-9 ]
4,5-Dibromo-2-phenylpyridazin-3(2H)-one
Similarity: 0.74
[ 1698-53-9 ]
4,5-Dichloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.70
[ 18048-64-1 ]
1-(3,4-Dimethylphenyl)-3-methyl-1H-pyrazol-5(4H)-one
Similarity: 0.70
[ 867130-83-4 ]
4-Amino-6-chloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.75
[ 14305-08-9 ]
4,5-Dibromo-2-phenylpyridazin-3(2H)-one
Similarity: 0.74
[ 1698-53-9 ]
4,5-Dichloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.70
[ 18048-64-1 ]
1-(3,4-Dimethylphenyl)-3-methyl-1H-pyrazol-5(4H)-one
Similarity: 0.70
[ 867130-83-4 ]
4-Amino-6-chloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.75
[ 41773-19-7 ]
5-(Dimethylamino)pyridazin-3(2H)-one hydrochloride
Similarity: 0.70
[ 4149-06-8 ]
3-Amino-1-phenyl-1H-pyrazol-5(4H)-one
Similarity: 0.70
[ 1672-58-8 ]
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide
Similarity: 0.68
[ 867130-83-4 ]
4-Amino-6-chloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.75
[ 14305-08-9 ]
4,5-Dibromo-2-phenylpyridazin-3(2H)-one
Similarity: 0.74
[ 1698-53-9 ]
4,5-Dichloro-2-phenylpyridazin-3(2H)-one
Similarity: 0.70
[ 41773-19-7 ]
5-(Dimethylamino)pyridazin-3(2H)-one hydrochloride
Similarity: 0.70
[ 2095779-74-9 ]
6-Chloro-2-(3,5-dimethoxyphenyl)pyridazin-3(2H)-one
Similarity: 0.69